At a Glance
Additional context: Draft guidance is intended for consultation and should not be described as final mandatory law. IVD manufacturers should check device risk class, quality-management requirements, technical documentation and the final published guidance before changing compliance procedures.
On 9 October 2026, CDSCO listed a draft guidance document for manufacturers of in-vitro diagnostic (IVD) medical devices for stakeholder comments.
Key points
- This is a draft consultation document, not a final binding rule.
- IVD manufacturers, laboratories and regulatory teams should examine the full guidance and any stated consultation deadlines before responding.
- Readers should check the official PDF for scope, technical requirements and applicability; these details should not be assumed from the notice title alone.
India relevance
IVD regulation affects manufacturers and diagnostic-service quality assurance in India.
Limitations
The public notice confirms publication of a draft; it does not establish a new approval, product recall or change to clinical diagnostic recommendations.
Official source
CDSCO public notices (9 October 2026).
Information only; follow the current official regulations and applicable clinical protocols.